Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Clemente

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Ebiomedicine|July 20, 2025
CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
AIDS (London, England)|August 29, 2024
Cancer in people with multidrug-resistant HIVTommaso Clemente, Domenico Pontillo, Vincenzo Malagnino, et al.
AIDS (London, England)|May 6, 2025
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIVTommaso Clemente, Michele Bellomo, Angelo Roberto Raccagni, et al.
AIDS (London, England)|May 28, 2026
Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registryAndrea Calcagno, Martina Strano, Riccardo Lolatto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 6, 2025
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registryTommaso Clemente, Mehdi Benlarbi, Rebecka Papaioannu Borjesson, et al.
The Journal of Antimicrobial Chemotherapy|July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral eraRebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
The Journal of Antimicrobial Chemotherapy|December 27, 2024
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registryTommaso Clemente, Sara Diotallevi, Davide Minisci, et al.
Viruses|September 27, 2025
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO RegistryFilippo Lagi, Michele Bellomo, Riccardo Lolatto, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2024
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO RegistryDaniele Armenia, Vincenzo Spagnuolo, Maria C Bellocchi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Ebiomedicine|July 20, 2025
CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
AIDS (London, England)|August 29, 2024
Cancer in people with multidrug-resistant HIVTommaso Clemente, Domenico Pontillo, Vincenzo Malagnino, et al.
AIDS (London, England)|May 6, 2025
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIVTommaso Clemente, Michele Bellomo, Angelo Roberto Raccagni, et al.
AIDS (London, England)|May 28, 2026
Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registryAndrea Calcagno, Martina Strano, Riccardo Lolatto, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 6, 2025
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registryTommaso Clemente, Mehdi Benlarbi, Rebecka Papaioannu Borjesson, et al.
The Journal of Antimicrobial Chemotherapy|July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral eraRebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
The Journal of Antimicrobial Chemotherapy|December 27, 2024
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registryTommaso Clemente, Sara Diotallevi, Davide Minisci, et al.
Viruses|September 27, 2025
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO RegistryFilippo Lagi, Michele Bellomo, Riccardo Lolatto, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2024
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO RegistryDaniele Armenia, Vincenzo Spagnuolo, Maria C Bellocchi, et al.
Pageof 4